written by reader Is Any Big Pharma Outfit NOT Interested in Buying This Little-Known Biotech?

by DrKSSMDPhD | June 3, 2014 4:30 pm

Here's to a "Green" Biotechnology Company....In A Manner of Speaking

This is premium content. To view this article (and to have full access to the rest of our articles), sign up. Already a member? Log in.

Source URL: https://www.stockgumshoe.com/2014/06/microblog-is-any-big-pharma-outfit-not-interested-in-buying-this-little-known-biotech/


740 responses to “written by reader Is Any Big Pharma Outfit NOT Interested in Buying This Little-Known Biotech?”

  1. biotechlong (btl) says:

    Re Post 277: Kenny, thanks so much for the detailed Shaw report on Benetic!

  2. Elliot says:

    I’m not sure if anyone follows this one, but Tetralogic (TLOG) appears to be breaking out of a long downtrend. This one was brought up a while ago, but fell by the wayside I think.
    Of those we follow, RNN also appears to be starting an uptrend, and BNIKF is breaking through its 30 day sma today (following BLT.AX per usual). RGDO has been holding above its 30 day sma nicely, but will face resistance from its 50 day sma today, at 6.86 … lets see if we can breakout above.

  3. roblites says:

    AF dropped another bomb on INO at about 10AM and it went down about 1.50 to around $8.55. Seems to have settled at $8.65+

  4. c193 says:

    Wow! That Shaw Report is something! (I think I need a cigarette!). Dr. KSS, do you think there is validity to the company’s research into macular degeneration and chronic pain treatment? Those would be two huge markets!

  5. Dan says:

    I’m starting to have a bit more confidence in Benitec management.

  6. Elliot says:

    CLDN really climbing on decent (but not larger than average) volume. Of course since I decided to hold off on buying this time until it cools off, it seems I have missed the boat.

  7. Dan says:

    I would expect that any stock price appreciation in BNIKF will be reflected in BTEBY when it begins trading. Thoughts?

  8. newby3867 says:

    Antisense Therapuetic looks fully funded into 2015 and looking to partner ATL-1102 and ATL-1103.http://www.theage.com.au/business/markets/quotes/announcement/ANP/antisense-therapeutics-limited/1522249 Cheers,Glenn

  9. newby3867 says:

    Ctix’s Brilacidin recent update.Everything looks well on all fronts.
    http://cellceutix.com/leading-technology-antibiotics-licensed-from-upenn/#sthash.NaEQ0zLR.dpbs Cheers,Glenn

  10. sassykind says:

    Hi Joe, Well, I hope turns out well for you…..I’d be thinking abt changing my broker. BUT have you asked any of the guys who did get free through Scottrade how they did it? Might be good ammo for when you make your move. Also does BNY Mellon know or care what these cowboys are doing? Anyway, however you do it, good luck. Sue.

  11. Dan says:

    herbalix,
    I too have reservations on this conversion mainly for the reason you gave. Paying Mellon a $25- $50 annual fee is one thing, but I have a big problem with an annual % fee as this would be devastating for returns. Has anyone looked into exactly what Mellon’s total charges will be for BTEBY shareholders?

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.